logo

Biotechnology & Drugs News

Share

AstraZeneca Says NEURO-TTRansform Phase III Trial Meets Co-primary Endpoints

EU Opens Investigation Into Possible Anticompetitive Disparagement By Vifor Pharma Of Iron Medicine

Sana : Data Shows Survival Of Transplanted Hypoimmune IPSC-Derived Differentiated Cell Types

Sandoz: EMA Accepts Application For Proposed Biosimilar Adalimumab's High Concentration Formulation

ObsEva: EC Grants Marketing Authorization For Yselty For Treatment Of Uterine Fibroids

Addex Ends Dipraglurant Phase 2b/3 Study For Dyskinesia Associated With Parkinson's Disease